Search results
Results from the WOW.Com Content Network
AstraZeneca's blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalisation and death in people with all types of heart failure, according to study data released ...
A separate study showed that fish-oil derived omega-3s may improve muscle mass, strength, and physical function in older adults with stable weight, and HMB improved both muscle mass and strength ...
Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.
Dapagliflozin is used along with diet, exercise, and usually with other glucose-lowering medications, to improve glycaemic control in adults with type 2 diabetes. . Dapagliflozin, in addition to other SGLT2-inhibitors, was shown to reduce the rate of decline in kidney function and kidney failure in non-diabetic and type 2 diabetic adults when added to the existing treatment
Mechanism of action of calcium sensitizers: increase sensitivity of troponin C to Ca2+ Calcium is a vital element for regulating the contraction and relaxation of the heart muscle. [6] Calcium sensitizers are medications that increase the responsiveness of heart muscle cells to calcium, enabling more forceful contractions while conserving ...
Combined with other heart disease risk factors, such as type 2 diabetes or high blood pressure, smoking increases the likelihood of developing heart disease even more. However, quitting can be ...
Antihypertensive agents comprise multiple classes of compounds that are intended to manage hypertension (high blood pressure). Antihypertensive therapy aims to maintain a blood pressure goal of <140/90 mmHg in all patients, as well as to prevent the progression or recurrence of cardiovascular diseases (CVD) in hypertensive patients with established CVD. [2]
Myostatin inhibitors can improve athletic performance and therefore there is a concern these inhibitors might be abused in the field of sports. [51] However, studies in mice suggest that myostatin inhibition does not directly increase the strength of individual muscle fibers. [52]